Tardive dyskinesia. Drug-induced dystonia
Conditions
Interventions
Intervention 1: in intervention group: Rivastigmine,1.5 mg capsules, twice a day, in 4 weeks. Intervention 2: in control group: sugar,1.5 mg capsules, twice a day, in 4 weeks.
Treatment - Drugs
in intervention group: Rivastigmine,1.5 mg capsules, twice a day, in 4 weeks.
in control group: sugar,1.5 mg capsules, twice a day, in 4 weeks.
Sponsors
University of Social Welfare and Rehabilitation Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age range between 18 to 65 years, Spent at least one year of treatment with antipsychotics, to have a stable condition of the patient for at least one month prior to study entry. Exclusion criteria: Organic brain disease, Any neurological disorders, Having a chronic health problem, Change in the amount or type of antipsychotic medication or tranquilizers were used during the last 6 months so that might affect the patient's motor symptoms, Patients with mental retardation, Patients with thyroid disorders, Diabetes, and Substance Abusers.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tardive dyskinesia symptoms. Timepoint: At baseline and after eight weeks follow-up. Method of measurement: Abnormal Involuntary Movement Scale (AIMS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Amirabbas Jahanian
University of Social Welfare and Rehabilitation
Outcome results
None listed